Biodetection Diagnosing Difficult-to-detect Pathogens in Central Nervous System InfectionsGlobal Biodefense StaffNovember 13, 2024
Medical Countermeasures FDA Removes Clinical Hold on Novavax’s Combo COVID-Flu VaccineGlobal Biodefense StaffNovember 11, 2024
Medical Countermeasures GigaGen Wins BARDA Contract to Develop Biothreat CountermeasuresGlobal Biodefense StaffOctober 3, 2024
BARDA-Supported Anthrax Vaccine Now Approved, Enables Faster Onset to Protection Industry News August 7, 2023 …
BD Gets FDA Clearance for Influenza, RSV, COVID-19 Respiratory Viral Panel Biodetection August 1, 2023 …
908 Devices Launches Remote and Continuous Area Monitoring for Aerosol and Vapor Detection Biodetection July 31, 2023 …
U.S. Invests in mAb Treatment for Ebola with New Award to Emergent BioSolutions Industry News July 31, 2023 …
After Missing the Mark in COVID Trial, Revive Therapeutics Pursues Bucillamine as CBRN Medical Countermeasure Industry News July 28, 2023 …
Smallpox Countermeasures: U.S. Awards $138M to Siga Technologies for TPOXX Industry News July 27, 2023 …
VitriVax Wins DoD Contract to Develop Single-Shot Vaccine for Melioidosis and Glanders Industry News July 19, 2023 …
DARPA Award to Ginkgo Bioworks Aims to Revolutionize Speed of Medical Countermeasure Manufacturing Industry News July 19, 2023 …
Revive Therapeutics Announces Results of Phase 3 Study for Bucillamine in the Treatment of COVID-19 Industry News July 6, 2023 …
A-Alpha Bio and Lawrence Livermore to Accelerate Antibody Discovery and Development for Biothreats Industry News May 16, 2023 …
Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding Industry News January 12, 2023 …
DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development Industry News January 10, 2023 …
Bavarian Nordic to Supply Additional Monkeypox Vaccine to EU Member States Industry News September 7, 2022 …
Arcturus Awarded $63.2M to Advance Self-amplifying mRNA Vaccine for Pandemic Influenza Response Industry News August 31, 2022 …
Mount Sinai Announces the Formation of Clinical-Stage Infectious Diseases Company CastleVax Industry News August 9, 2022 …
Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs Industry News June 20, 2022 …